This work is licensed under a Creative Commons Attribution 4.0 International License.
Cathelicidin (135-146)-CAP7 (1-12), Tylotoin-sC18*
General Information
DRACP ID DRACP03733
Peptide Name Cathelicidin (135-146)-CAP7 (1-12), Tylotoin-sC18*
Sequence KCVRQNNKRVCKGLRKRLRKFRNK
Sequence Length 24
UniProt ID W0FJD1
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C128H234N52O29S2
Absent amino acids ADEHIMPSTWY
Common amino acids KR
Mass 344013
Pl 12.53
Basic residues 12
Acidic residues 0
Hydrophobic residues 5
Net charge 12
Boman Index -12388
Hydrophobicity -170.83
Aliphatic Index 56.67
Half Life
Mammalian: 1.3 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 125
Absorbance 280nm 5.43
Polar residues 6
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 30389988
Title Design of a novel cell-permeable chimeric peptide to promote wound healing
Doi Not available
Year 2018
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 12018
This work is licensed under a Creative Commons Attribution 4.0 International License.